Use of shatavari in heavy periods.

Effect of shatavari churna and shatavari taila uttarbasti in atyartava

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014130

Enrollment

Registered

2018-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Heavy bleeding per vaginum during menses since 3 months or more

Interventions

Intervention1: Group A: Group A (20 patients) received shatavari churna orally 3 grams BD for three months. Control Intervention1: Group B: Group B ( 20 patients) received uttarbasti with shatavari ta

Eligibility

Inclusion criteria

Inclusion criteria: Married women,having complaint of heavy bleeding per vaginum during menses for three months or more.

Exclusion criteria

Exclusion criteria: Unmarried women, using any hormonal preparation, history of recent delivery or abortion, suffering from any chronic illness, psychiatric patients

Design outcomes

Primary

Measure	Time frame
Relief in heavy bleeding per vaginum during menses, change in endometrial thickness, change in the level of serum estradiolTimepoint: 4 months	—

Secondary

Measure	Time frame
Relief in pain in abdomen during menses, relief in backache during menses, relief in nausea during menses, relief in tingling sensation and numbness.Timepoint: 4 months	—

Countries

India

Contacts

Public ContactSunita Suman

Faculty of ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi

ssom18@gmail.com7607165096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026